ERBB2 and breast carcinoma: Breast cancer is classified into subtypes based on immunohistochemical biomarkers, including estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) (Yeo and Guan, 2017).